Schizophrenia

Active Ingredient: Olanzapine

Indication for Olanzapine

Population group: only elderly (65 years old or older)

Olanzapine is indicated for the treatment of schizophrenia.

For this indication, competent medicine agencies globally authorize below treatments:

5-20 mg once daily

Route of admnistration

Oral

Defined daily dose

5 - 20 mg

Dosage regimen

From 5 To 20 mg once every day

Loading dose

5 mg

Detailed description

A lower starting dose (5 mg/day) is not routinely indicated but should be considered for those 65 and over when clinical factors warrant.

The recommended starting dose for olanzapine is 10 mg/day.

During treatment for schizophrenia, manic episode and recurrence prevention in bipolar disorder, daily dosage may subsequently be adjusted on the basis of individual clinical status within the range 5-20 mg/day. An increase to a dose greater than the recommended starting dose is advised only after appropriate clinical reassessment and should generally occur at intervals of not less than 24 hours. Olanzapine can be given without regards for meals as absorption is not affected by food. Gradual tapering of the dose should be considered when discontinuing olanzapine.

Dosage considerations

Olanzapine can be given without regards for meals as absorption is not affected by food.

2.5-20 mg daily

Route of admnistration

Intramuscular

Defined daily dose

2.5 - 20 mg

Dosage regimen

From 2.5 To 20 mg once every day

Loading dose

2.5 mg

Detailed description

For intramuscular use. Do not administer intravenously or subcutaneously. Olanzapine powder for solution for injection is intended for short term use only, for up to a maximum of three consecutive days.

The recommended starting dose in elderly patients (>60 years) is 2.5-5 mg. Depending on the patient’s clinical status, a second injection, 2.5-5 mg, may be administered 2 hours after the first injection. Not more than 3 injections should be given in any 24 hour period and the maximum daily dose of 20 mg (including all formulations) of olanzapine should not be exceeded.

Active ingredient

Olanzapine

Olanzapine is an antipsychotic, antimanic and mood stabilising agent that demonstrates a broad pharmacologic profile across a number of receptor systems.

Read more about Olanzapine

Related medicines

Develop a tailored medication plan for your case, considering factors such as age, gender, and health history

Ask the Reasoner

Liability Disclaimer : RxReasoner has utilized reasonable care in providing content and services that are accurate, complete and up to date. However, RxReasoner does not accept any responsibility or liability about it. The content and services of RxReasoner are for informational purposes only and they are not intended to be a substitute for the knowledge, expertise, skill, and judgment of physicians, pharmacists, nurses, or other healthcare professionals involved in patient care. RxReasoner offers no medical advice. Users are responsible for the use of the provided content. A shown indication or treatment should not be construed to indicate that the medication is safe, appropriate, or effective in any given patient or under any particular circumstances. The absence of an indication or treatment should not roule out the existence of other appropriate medications. Always seek the advice of a physician or other qualified health provider with any questions you may have regarding a medical condition or medicament. RxReasoner is not liable for any damages allegedly sustained arising out of the use of its content and services.